Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ahvaz Jundishapur University of Medical Sciences

Study on Anti-Hepatitis B Surface Antibody Titer and Specific Interferon Gamma Response Among Dentists

Makvandi, Manoochehr and Rasti, Mojtaba and Sarmast, Mohammad Hosein and Sadeghi Haj, Mehrdad and Rastegarvand, Nasrin and Khalafkhani, Dawood and Samiei, Rahil Nahid and Shabani, Abdulnabi and Karimi Babaahmadi, Mohammad and Jalilian, Shahram and Ahmadi Angali, Kambiz and Shahani, Toran and Varnasari, Mehran (2017) Study on Anti-Hepatitis B Surface Antibody Titer and Specific Interferon Gamma Response Among Dentists. Jentashapir Journal of Health Research, In Pre (In Pre). ISSN 2345-4067

[img]
Preview
Text
3.pdf

Download (128kB) | Preview
Official URL: http://doi.org/10.5812/jjhr.37477

Abstract

Background: Hepatitis B virus (HBV) is a major problem for healthcare workers worldwide, and among them, dentists are at risk of acquiring HBV infection. The prevalence of HBV infection has been reported among the dentists in different regions of the world. Since none of the available drugs can clear HBV infection, the presence of effective immunity against HBV infection is important to prevent HBV infection. Objectives: This study aimed at determining HBs antibody and specific HBV gamma interferon among the dentists, who received hepatitis B vaccine. Methods: The blood samples were collected from 40 dentists, including 7 endodontics, 2 oral and maxillofacial radiologist, 4 periodontics, 11 oral and maxillofacial surgeons, 6 implantologists, 3 orthodontics, 1 oral and maxillofacial pathologist, 2 esthetic and restorative dentists, and 4 doctors of dental surgery (DDS) at from dental college of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran during December, 2013. Overall, 31 (77.5%) dentists had already received 3 doses of recombinant hepatitis B vaccine, and 9 (22.5%) had received only two doses of the vaccine. Their sera were tested for HBsAb and anti-HBc-IgG by the Enzyme Linked Immunosorbent Assay (ELISA) test. The lymphocyte of individuals was separated from their blood sample by Ficoll-Hypaque, cells were washed with phosphate buffered saline (PBS) by centrifugation, and finally the pellet cells was resuspended in RPMI-1640 media. Separated cells were exposed to 2.5�g of purified recombinant HBs antigen, and supernatants were collected after 72 hours and tested for detection of specific interferon level by ELISA test. Results: Overall, 97.5% of dentists showed positive HBs antibody test results while 36 showed (90%) positive test results for specific interferon against hepatitis B virus infection. Conclusions: High coverage of 97.5% immune response against hepatitis B infection was found, indicating high efficacy of recombinant HBV vaccine among the dentists. Keywords: Hepatitis B Virus, Hbsab, Interferon Gamma, Health CareWorkers

Item Type: Article
Keywords: Keywords: Hepatitis B Virus, Hbsab, Interferon Gamma, Health CareWorkers
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: آقای بهرام سوسنی غریب وند
Date Deposited: 05 May 2018 07:54
Last Modified: 05 May 2018 07:54
URI: http://eprints.ajums.ac.ir/id/eprint/11449

Actions (login required)

View Item View Item